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SObjective: Quality of life after pulmonary resection is becoming an increasingly important part of the conver-
sation between patients and surgeons. Pneumonectomy is often called a disease. The objective of this study was
to assess the physical and mental aspects of patients’ quality of life at least 1 year after pneumonectomy.
Methods: Quality of life was ascertained using the Short Form-12 (SF-12) survey on a consecutive series of
patients whowere at least 1 year postoperative from a pneumonectomy. Both the physical andmental component
scores of the quality-of-life survey were obtained and compared.
Results: There were 152 patients who underwent pneumonectomy between January 1997 and December 2010
by the same surgeon (104 for non–small cell lung cancer); 111 patients met the eligibility criteria. Mean survival
was 3.4 years and the overall 5-year Kaplan-Meier survival was 38%. Responses to the quality-of-life survey
were obtained in 108 of 111 patients (98%) who were at least 1 year postoperative. The overall quality-of-
life score was comparable with that of the healthy population and patients with chronic diseases. The mean
physical component score was significantly lower than that of the healthy population score (P¼ .04); the mental
quality-of-life score was higher than those for patients with certain chronic diseases such as liver or kidney dis-
ease (P¼ .05). After multivariate analysis, only age remained a significant predictor of the physical component
score.
Conclusions: Pneumonectomy is tolerated in carefully selected patients. The physical quality-of-life score
1 year after resection is significantly lower than the average population, yet the mental score in these patients
is higher. Future studies on quality of life should be considered for all medical therapies, and stratification of
the mental score from the physical score should be reported. (J Thorac Cardiovasc Surg 2012;144:1139-45)GQuality of life (QOL) is becoming an increasingly impor-
tant part of the conversation between patients and
physicians. Most patients are willing to accept the risks of
immediate postoperative complications, yet not the risks
of potential long-term functional disability after lung resec-
tion. Patients want reassurance that they will not be left
physically or mentally handicapped andwill be able to carry
out activities of daily life after pulmonary resection.1
Pneumonectomy is often referred to as a disease. Graham
and Singer2 reported the first successful pneumonectomy at
the American Association of Thoracic Surgery annual
meeting in 1933. Since that initial presentation, there
remains much controversy surrounding this operation not
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The Journal of Thoracic and Carregard to the long-term detrimental impact on QOL.3-5
Many clinicians argue that patients who undergo
pneumonectomy subsequently have a poor QOL, and
therefore surgeons should only select it as a last option.6,7
Few reports have evaluated the long-term (1 year post-
operatively) mental and physical components of QOL in
larger postpneumonectomy cohorts. The objective of this
study was to assess the postoperative mental and physical
QOL scores using the Short Form-12 (SF-12) survey in
a consecutive series of patients who underwent pneumonec-
tomy 1 year after pneumonectomy.METHODS
This was a prospective cross-sectional study to evaluate the long-term
impact on QOL of a consecutive series of patients who underwent pneumo-
nectomy by the same general thoracic surgeon (R.J.C.). Pneumonectomy
was performed on patients with non–small cell lung cancer only if sleeve
resection of the bronchus or artery could not render a negative margin.
We have reported previously our indication and workup for patients with
non–small cell lung cancer and our technique for attempting sleeve resec-
tions of the artery and bronchus.8,9 No absolute threshold for
a postoperative predicted percent diffusing capacity of the lung for
carbon monoxide (DLCO%) or percent forced expiratory volume in 1
second (FEV1%) was used below which pneumonectomy was denied;
however, in general, a postoperative predicted DLCO of 30% and
a postoperative predicted FEV1 of 30% was used. Patients who were
<19 years of age at the time of surgery were excluded from this study. In
addition, pneumonectomy was sometimes performed for patients with
benign disease with a destroyed lung. These patients were included in
this study to elucidate more clearly the difference between cancer
patients and those with inflammatory disease. The indications fordiovascular Surgery c Volume 144, Number 5 1139
Abbreviations and Acronyms
DLCO ¼ diffusing capacity of the lung for
carbon monoxide
FEV1 ¼ forced expiratory volume in 1 second
IRB ¼ institutional review board
QOL ¼ quality of life
PFT ¼ pulmonary function test
SF-12 ¼ Short Form-12
SF-12 ¼ Short Form-36
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Spneumonectomy for inflammatory diseases have been described
previously.10 Prior to pneumonectomy, patients underwent pulmonary
function tests (PFTs), computed tomographic scan, ventilation/perfusion
scan, and echocardiogram, and were asked to assess their own performance
status using the Eastern Cooperative Oncology Group performance status
score.11
Starting in 2003, the SF-12 survey was administered to all patients who
had undergone a pneumonectomy since 1996. After 2003 the survey was
administered prospectively to patients 1 year after they underwent a pneu-
monectomy. SF-12 is a shorter version of the standard Short Form 36
(SF-36), and it is also a validated tool used to assess the patient’s QOL;
it permits calculation of a physical component score and a mental compo-
nent score.12 Appendix 1 shows the SF-12 survey used in this study. Re-
sponses were stratified by the physical and mental components scores;
these scores range from 0 (lowest level of health) to 100 (highest level of
health). The national normalized value (as validated by Quality Metric
Inc, Lincoln, RI) is 50.0with a standard deviation of 10.13Mental and phys-
ical component scores of these patients were compared with scores ob-
tained for healthy patients; the general U.S. population; and patients with
diabetes, hypertension, and liver or kidney diseases as reported by the Na-
tional Survey of Functional Health Status.12 A higher mental component
score indicates a positive effect, absence of psychological distress, and lim-
itations in usual social or role activities as a result of emotional problems;
a higher physical score indicates fewer physical limitations, disabilities, or
decrements in well-being as well as a high energy level.13
Major morbidity was defined as we have described previously.8 Opera-
tive mortality was defined as death within 30 days of the operation or prior
to discharge. Information was obtained through hospital databases, medical
records, and/or family reports. Data were exported from Excel (Microsoft
Corp, Seattle, Wash) to SAS version 9.1 (SAS Institute, Cary, NC) soft-
ware. Descriptive statistics were used to estimate the frequency of categor-
ical and median of the continuous study variables. Subgroups analysis,
which consisted of comparison of mental and physical scores stratified
by age, gender, indication for operation, final pathologic stage, neo-
adjuvant therapy, and comorbidity, were performed by means of the
Mann-Whitney U test. Comparisons were done with paired, 2-tailed t tests
for means of normally distributed continuous variables and Wilcoxon rank
sum tests for skewed data. Either the c2 or the Fisher exact test was used to
compare categorical data. A stepwise multivariate logistic regression
model was used to assess for any correlation of QOL score with subgroups.
The University of Alabama at Birmingham’s institutional review board
(IRB) approved this protocol (E100827024) as well as the prospective da-
tabase (X030403013) used to collect information for this study. Individual
consent was waived for inclusion in this study; however, it was required and
obtained to enter patient data in the prospective database.RESULTS
Between January 1997 and December 2011, 152 patients
underwent a pneumonectomy. Of the 152 patients, 21140 The Journal of Thoracic and Cardiovascular Surpatients were excluded as a result of age<19 years, 11 pa-
tients died within 90 days of surgery, and 29 patients died
within 1 year of surgery, thus leaving 111 patients eligible
for this study. The characteristics of these 111 patients are
shown in Table 1. A major postoperative morbidity
occurred in 37 patients (23%), including the 10 patients
(6.7%) who had an operative mortality. The mean survival
was 3.4 years and the overall 5-year Kaplan-Meier survival
was 37%.
Responses to the SF-12 QOL survey were obtained in 108
of the 111 patients (98%) whowere alive at least 1 year post-
operatively. Table 213 shows that the mean physical compo-
nent score in our cohort was significantly lower than that of
the average U.S. population’s score (P ¼ .02), whereas the
mental QOL score was significantly higher (P ¼ .03).
Univariate analysis of patient characteristics showed that
mental QOL differed significantly b: gender (females had
a higher mental component score than males, P<.001), in-
dication for surgery (patients who underwent resection for
malignancy had a higher mental score, P < .001), and
disease recurrence (patients who had a recurrence had lower
mental scores). There was no significant difference
observed based on age, preoperative PFTs, neo-adjuvant
therapy, final pathologic stage, smoking status, or comor-
bidity. On multivariate analysis, none of these factors
remained significantly associated with the mental QOL
score. Univariate analysis showed that physical QOL dif-
fered significantly by age (older patients had a lower phys-
ical component score, P ¼ .01), FEV1% score (patients
with a higher FEV1% had a higher physical component
score, P<.001), and indication for surgery (patients under-
going surgery for malignancy had a higher physical score,
P ¼ .05). There were no significant differences observed
based on gender, DLCO%, neo-adjuvant therapy, final
pathologic stage, smoking status, comorbidity, or recur-
rence. On multivariate analysis, only age remained
significantly associated with the physical component score
(P ¼ .02).
DISCUSSION
General thoracic surgeons try to avoid pneumonectomy
in patients with lung cancer because of the reported poor
QOL, increased morbidity and mortality, and the impres-
sion that a pneumonectomy is, in and of itself, a disease.
However, sometimes a pneumonectomy is the only way to
achieve an R0 resection. In general, it should be reserved
for patients who are N2 lymph node negative, have accept-
able pulmonary and cardiac function, and suitable perfor-
mance status. Interestingly, pneumonectomy is often not
offered for patients who have a metastatic lesion to the
lung because of the opinion that it offers only local control
and it has an associated poor QOL. The perception that
a patient postpneumonectomy has a poor QOL secondary
to physiologic impairment was the impetus for this study.gery c November 2012
TABLE 1. Patient characteristics (preoperative) of the 111 patients
eligible for the study
Characteristic Value
Age, y (range) 58 (19-73)
Male, n (%) 54 (49)
Current smoker (quit<1 mo prior to surgery), n (%) 23 (21)
Preoperative PFTs
FEV1% (SD) 76 (12)
DLCO% (SD) 72 (14)
PaO2, mm Hg (range) 72 (66-88)
PaCO2, mm Hg (range) 42 (39-45)
Preoperative ECOG status (range) 1 (0-2)
Neo-adjuvant treatment, n (%) 32 (29)
Indication for surgery, n (%)
Malignant lesion 97 (87)
Benign (infection) 14 (13)
Side of pneumonectomy, n (%)
Right 58 (52)
Left 53 (48)




PFT, Pulmonary function test; FEV1, forced expiratory volume in 1 second; SD,
standard deviation; DLCO, diffusing capacity of the lung for carbon monoxide;
PaO2, partial pressure of oxygen in blood; PaCO2, partial pressure of carbon dioxide
in blood; ECOG, electrocorticogram.
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SThere are few data in the literature that evaluate QOL in
patients postpneumonectomy, and none that evaluate the
long-term mental and physical QOL scores 1 year after
pneumonectomy.
Leo and colleagues,14 in 2010, evaluated QOL using
a Quality of Life Component 30 survey pre- and 6 months
postoperatively in 41 patients who had a pneumonectomy.
They found that 1 of 4 patients reported a significantly de-
creased QOL 6 months postoperatively. Similar to our re-
sults, they also reported that patients who were>70 years
of age at the time of surgery had a significantly poorer QOL.
Deslauriers and associates,4 in 2011, evaluated QOL of
100 patients that were 5 years postpneumonectomy.
They used physiologic studies as a surrogate for QOLTABLE 2. Mental and physical component scores of postpneumonec-
tomy patients compared with general US populations, including





Healthy adults 52.3 (7.9) 54.3 (6.2)
General U.S. population 49.4 (9.8) 49.6 (9.9)
Hypertension 49.1 (9.5) 43.7 (10.3)
Diabetes mellitus 47.3 (10.7) 41.5 (11.1)
Kidney disease 45.2 (10.1) 37.9 (11.2)
Liver disease 44.1 (12.9) 42.0 (12.1)
Postpneumonectomy patients 52.1 (10.7) 35.8 (8.9)
SD, Standard deviation.
The Journal of Thoracic and Carand showed that most patients were able to adjust to living
a ‘‘near-normal life’’ after pneumonectomy. Their conclu-
sions were derived from an evaluation of physiologic pa-
rameters, which included FEV1%, DLCO%, maximal
oxygen uptake, 6-minute walk test, chest roentgenogram,
ipsilateral diaphragmatic motion, phrenic nerve conduction,
and echocardiography. Their findings provided unique
physiologic information; however, QOL was not assessed
in this study.
Brunelli and coworkers,15 in 2007, showed there was
little correlation between QOL measurements and the
physiologic tests physicians often order to assess QOL.
They administered the SF-36 survey to 156 patients who un-
derwent pulmonary resection, 12 of whom had a pneumo-
nectomy. They surveyed patients preoperatively and at
1 and 3 months after resection. Similar to our findings,
they showed in their patients postpneumonectomy that their
physical component scores were decreased significantly
and yet their mental component scores were unchanged.
Our results show that 1 year after pneumonectomy,
patients have comparable mental scores with that of the
general population; the mean mental score was actually
higher than patients with other chronic diseases. This differ-
ence persisted even in patients who had both a pneumonec-
tomy and a chronic illness such as diabetes mellitus or heart
disease, or who received neo-adjuvant therapy. This higher
mental score may be attributed to the fact that most patients
in our series had a malignancy; cancer patients who have
been completely resected often report a higher mental
score.
When we compared the patients who had a pneumonec-
tomy for cancer with those who had a pneumonectomy for
benign disease, the mental score and physical score were
both significantly higher in the patients who had the pneu-
monectomy performed for malignancy. This further sup-
ports the theory that patients who have cancer who
undergo resection report higher mental scores. In this study,
we also found that women reported a higher mental score
than men, and relatively similar physical scores. These
findings are in contrast to Ilonen and colleagues,16 who re-
ported a significantly lower QOL in women who underwent
pneumonectomy. There was no significant difference in the
mental score based on age. However, not surprisingly, the
physical scores of the younger cohort were significantly
higher than those of older patients.
The strengths of our study include the large number of
patients followed over a long time period; all procedures
were performed by the same surgeon who used similar
pre-, intra-, and postoperative protocols; the large sample
size of patients postpneumonectomy only; high response
rate to the surveys (98%); and the fact that the SF-12 is
a validated, standardized survey.
Limitations of this study include the inherent subjectiv-
ity of any study on QOL. Other limitations include the factdiovascular Surgery c Volume 144, Number 5 1141
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ducible and precise scores compared with its longer SF-
36 counterpart. However, we opted to use the SF-12 survey
in lieu of its longer counterpart or other QOL surveys that
may yield additional information as a tradeoff for a higher
response rate. In our experience, patients are less likely to
complete and return longer surveys; they are more accurate
when they use shorter ones. In addition, the survey was
only administered 1 year postoperatively; consequently,
our results do not reflect QOL of patients who died prior
to that. These patients may have had the lowest QOL scores
as well as lower PFT scores, which could explain why pul-
monary function was not associated significantly with QOL
outcome in this study. We did not administer the survey
both pre- and postoperatively, and thus we were unable to
evaluate changes from baseline values or temporal
changes. Our study is different from other studies because
27% of our patients underwent completion pneumonec-
tomy. These operations are often more difficult and this
could have skewed our results and increased morbidity
and mortality. In addition, patients who have pneumonec-
tomy for benign disease often have a lower QOL preoper-
atively than those with cancer, and this, too, may have
skewed our results and lowered the QOL data falsely.
Thus, whether the old adage that ‘‘pneumonectomy is
a disease’’ is true depends on the definition of the word
disease. In this study, we tried to define what a disease is
by using QOL information for patients with common dis-
eases such as diabetes mellitus, kidney disease, and hyper-
tension. We found that patients postpneumonectomy have
similar QOL scores, and thus pneumonectomy is a disease.
Our results were surprising to us and showed the relatively
marginal QOL these patients have 1 year after pneumonec-
tomy and the high 1-year mortality rate. However, like
many other diseases, pneumonectomy can be well
tolerated.
We conclude that, in carefully selected patients, a pneu-
monectomy is an acceptable operation. However, pneumo-
nectomy reduces significantly a patient’s physical score on
the QOL survey, particularly in elderly patients. Given the
higher mental QOL scores in our cohort, the notion that
this operation leaves a patient in an unfit state is not sup-
ported by the patient’s perception of their own functional
status. The improved mental QOL score may be attributed
to the fact that the majority of patients in our series had
cancer, and studies have shown that patients who have
been completely resected are more optimistic overall. How-
ever, the depressed physical QOL scores should be related
to patients prior to surgery. QOL measurement is becoming
an increasingly important aspect of all types of medical
therapies. Prospective multicenter studies that evaluate
both physiologic and QOL scores pre- and then postopera-
tively every 6 months for at least 5 years after pneumonec-
tomy are needed.1142 The Journal of Thoracic and Cardiovascular SurReferences
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___ PoorThe following two questions are about activities you
might do during a typical day. Does YOUR HEALTH
NOW LIMIT YOU in these activities? If so, how much?
2. MODERATE ACTIVITES, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf:___ Yes, limited a lot
___ Yes, limited a little
___ No, not limited at allc November 2012
Bryant et al General Thoracic SurgeryClimbing several flights of stairs:
___ Yes, limited a lot
___ Yes, limited a little
___ No, not limited at allDuring the PAST 4 WEEKS have you had any of the fol-
lowing problems with your work or other regular activities
AS A RESULT OF YOUR PHYSICAL HEALTH?
3. Accomplished less than you would like:___ Yes
___ No4. Were limited in the KIND of work or other activities:___ Yes
___ NoSDuring the PAST 4WEEKS, were you limited in the kind
of work you do or other regular activities ASARESULTOF
ANY EMOTIONAL PROBLEMS (such as feeling de-
pressed or anxious)?
5. ACCOMPLISHED LESS than you would like:G
T___ Yes
___ No6. Didn’t do work or other activities as CAREFULLY as
usual:___ Yes
___ No7. During the PAST 4 WEEKS, how much did PAIN inter-
fere with your normal work (including both work outside
the home and housework)?___ Not at all
___ A little bit
___ Moderately
___ Quite a bit
___ ExtremelyThe next three questions are about how you feel and how
things have been DURING THE PAST 4WEEKS. For each
question, please give the one answer that comes closest to
the way you have been feeling. How much of the time
during the PAST 4 WEEKS
8. Have you felt calm and peaceful?___ All of the time
___ Most of the time
___ A good bit of the time
___ Some of the timeThe Journal of Thoracic and Cardiov___ A little bit of the time
___ None of the time9. Did you have a lot of energy?___ All of the time
___ Most of the time
___ A good bit of the time
___ Some of the time
___ A little bit of the time
___ None of the time10. Have you felt downhearted and blue?___ All of the time
___ Most of the time
___ A good bit of the time
___ Some of the time
___ A little bit of the time
___ None of the time11. During the PAST 4WEEKS, how much of the time has
your PHYSICAL HEALTH OR EMOTIONAL PROB-
LEMS interfered with your social activities (like visit-
ing with friends, relatives, etc.)?___ All of the time
___ Most of the time
___ A good bit of the time
___ Some of the time
___ A little bit of the time
___ None of the timeDiscussion
Dr Gary W. Chmielewski (Chicago, Ill). I would like to con-
gratulate Dr Bryant on a good presentation and I would like to
thank the authors for getting the manuscript to Dr Liptay and I
before the meeting. Dr Liptay and I would like to thank the Asso-
ciation for the chance to review this and discuss.
As surgeons, we have 2 goals in performing a pulmonary resec-
tion. One is to get rid of the cancer and the other is to get patients
back to their lives. The authors are to be congratulated on looking
at the second part of the equation, which most often is overlooked.
In this paper, the authors look at postoperative QOL scores in
patients undergoing pneumonectomy. They report on 111 patients
operated on during a 13-year period. Five-year survivals were
37%, with QOL scores obtained in 98% of these patients who
were out 1 year from surgery. In summary, the mental quality of
life scores were better compared with to the average population
whereas the physical component score was significantly worse
than the average population. As was pointed out here, in their ar-
ticle the authors state that it’s a misnomer to call a pneumonectomy
a disease, and they also emphasized the need to use separateascular Surgery c Volume 144, Number 5 1143
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on our patients’ quality of life. Although I agree with the authors
that the QOL scores are important in looking at our overall surgical
results, it does appear from your data that we are inducing some-
what of a chronic disease state on these patients, because they do
have QOL scores physically that are worse than patients with heart
disease, renal disease, and diabetes mellitus.
That said, I have 3 questions. The first 2 are: Now that your in-
stitution is armed with these data, do your surgeons plan to give
a preoperative QOL questionnaire and, if there are surgeons in
the audience who are inclined to go ahead and use these question-
naires in their postoperative care, what interval do you suggest that
we query our patients on?
Dr Bryant. Based on these data, we do plan to implement not
only just the QOL survey but physiologic measurements as well,
such as PFTs and a 6-minute walk test. I think a 6-month interval
for the first few years postoperatively would be ideal, and then
yearly for the remainder of the patient’s life, or as far as
possible.
Dr Chmielewski. This is an uncommon circumstance, but did
you see any dramatic differences in the QOL scores in the rare
patient who required a right pneumonectomy who also received
neo-adjuvant therapy compared with the rest of the group?
Dr Bryant. In our patient cohort we did not see any differences.
Dr Chmielewski.My final question is: Have your data resulted
in the surgeons at your institution selecting patients differently for
pneumonectomy or, I guess I’d like to ask Cerf, do you plan to
manage any of these preoperative or postoperative parameters dif-
ferently so that we can improve on our patients’ QOL?
Dr Cerfolio. This is the one that Cam should be getting up and
giving me the business on, not the other one. This paper was really
Dr Bryant’s idea, not mine—QOL. I said, you know, QOL, really,
I’m a surgeon. But these are great data. And when she collected the
data, I was really depressed to see several things: That 40 patients
out of 150 are dead at a year. That’s embarrassing, but that’s my
own data. They were all R0 resections and they all were N2 nega-
tive on mediastinoscopy, endobronchial ultrasound, or frozen at
the time of surgery. I think 6 or 7 ended up having N2 positive
on final pathology. But I thought I picked the best of the best,
and 1 in 3 are dead at a year. That’s not very good.
Dr Shrager.Most of them were stage IB, right? That would be
better than the published data for stage IB.
Dr Cerfolio. Well, I appreciate you saying that, but I’m not
happy with the results. And then to find out that the two thirds
who are alive aren’t really very happy with their QOL, especially
if they’re old. So I have gotten less aggressive. So now it looks like
the only way to get an R0 resection is to do a pneumonectomy. I am
having a different conversation since Dr Bryant has presented me
with this data, to be honest. My initial thing when I wrote the
abstract was, oh, pneumonectomy is a disease really is a misnomer;
it’s not a disease, but it depends how you define disease, and if you
define hypertension and diabetes mellitus and chronic liver disease
as a disease, and I guess we should, then a pneumonectomy is
a disease, and so I’m wrong. What else new?
Dr Todd L. Demmy (Buffalo, NY). The SF-12 is an abbreviated
form of the SF-36. The 2 dimensions on these studies that people
get a major effect after lung resection tend to be dyspnea and pain.
Is the ability to measure those dimensions reduced on the SF-12?1144 The Journal of Thoracic and Cardiovascular SurDr Bryant. On the SF-12, the questions that are asked are more
about are you able to perform your activities of daily life. Indi-
rectly, it’s asking about their functional status. We actually added
a few questions in our survey that address specifically those issues,
pain, but we did not find any correlations.
Dr Demmy. It’s interesting to study that interaction because
with more lung resected there is more muscle use, probably aggra-
vating the chronic pain mechanism. So I think you should look at
that. The other data point that tends to categorize the QOL on these
surveys is diffusing capacity rather than FEV1. Did you break out
your scores based on the DLCO?
Dr Bryant. We did. We looked at both FEV1 and DLCO. We
did not find a correlation with DLCO. It may be that the patients
with the poorest PFT status may have expired within that first year.
DrDemmy.Usually as you approach 40%DLCO, that’s a group
that does much worse with QOL. So you should analyze based on
those levels of residual diffusing capacity.
Dr Rafael S. Andrade (Minneapolis, Minn). I’m very im-
pressed with compliance of 98% in answering the surveys, which
I think would be good for a clinical trial. How did you actually do
that? In Minnesota, the IRB is very insistent that you can contact
patients maybe up to 3 times by letter, but you can’t be hammering
them. And some of these patients are 12 years out. They have no
reason to come back. How did you get 98% compliance?
Dr Bryant.We primarily mailed the surveys and then followed
up with a phone call. Our IRB did not make a stipulation of how
many times we could contact them. Every patient that Dr Cerfolio
has operated on since 1996, we have obtained permission to in-
clude their data in his prospective database, and we tell them up
front that this may be used for research. I think that’s one of the
reasons that the IRB gave us permission and allowed us to waive
consent. But it was very aggressive mail-outs and phone calls to
get that 98% response.
Dr Betty C. Tong (Durham, NC). I have 2 questions. First, how
do you think your data might be different or more robust if you had
longitudinal data?
Dr Bryant. I think it would help with assessing temporal
changes.
Dr Tong. Second, would you discuss a little bit how you chose
the SF-12 as your measure of QOL rather than another validated
measure, such as the European Organization for Research and
Treatment of Cancer (EORTC) Quality of Life Component 30
with the LC13 module, which is geared specifically toward pa-
tients with lung cancer.
Dr Bryant.We chose the SF-12 primarily because it’s a shorter
version of the survey and we were trading off compliance and pa-
tient response. With the longer surveys we found that patients
often didn’t respond or the survey was incomplete. With the SF-
12, we found that they are more likely to respond and complete
the survey.
Dr Tong. I think that the EORTCQuality of Life Component 30
with the LC13module, although longer, would address some of the
things that Dr Demmy had highlighted with regard to pain, short-
ness of breath, and other symptoms.
Dr Cerfolio. I would like to add one response to that. We tried
that before and failed. Patients in Alabama, and maybe it’s
Alabama, but people who come to see me, they’re not going to
spend time filling out more forms than they already have to justgery c November 2012
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Sfor the hospital and insurance company, and now answering more
questions for research stuff. Sowe did that before and we had a low
compliance. This is much higher with the 12 instead of the 36.
Dr David J. Sugarbaker (Boston, Mass). I just wanted to
congratulate Dr Cerfolio and the group on a really carefully
done study. I think it really highlights that when you say the
word pneumonectomy, it means different things to different peo-
ple, and if you select your patients well and the operation goes
well, those patients can live a very happy, relatively normal life.
So when you hear people talk about pneumonectomy, or even ex-
trapleural pneumonectomy, it means different things to different
people, but I think what these data show is that it can mean good
things for our patients. Congratulations.
Dr Gail Darling (Toronto, Ontario, Canada). I would just like
to follow along on the previous question about the instrument that
was chosen. I congratulate you for addressing QOL in our patients,
but I think, as surgeons, we should remember that QOL is not just
physical symptoms and debility and that sort of thing. There are
many other components to QOL. It’s not just their FEV1 or their
pain scores. I think some of the other instruments, the EORTC in-
strument, the FACT, measure some of these other dimensions of
QOL, including things like emotional well-being, social well-
being, functional well-being, which are not really captured by
the SF-12 or SF-36.
Dr Bryant. Thank you.
Dr Gaetano Rocco (Naples, Italy). I would like to ask a ques-
tion, Cerf. Could confounding factors in the analysis of the results
be the age threshold that you chose of 58 and the fact that more
than 10% of these patients were completion pneumonectomies?
DrCerfolio. I appreciate you trying to make me feel better. Yes.
Some of these were completion pneumonectomies and some of
these were destroyed lungs and difficult operations—not justThe Journal of Thoracic and Carcancer patients—but I have to also look in the mirror and be honest
and reflective about the poor reflection that is not very appealing,
and say that a 9-out-of-150 operative mortality and then an 11-out-
of-150 90-day mortality is not so good, and another 29 died within
a year. That’s pretty ugly. I think they were a sick group of patients,
I agree, but I think everybody in this room operates on a group of
sick patients. Howwould they have done if they had never meet me
is the other question we need more data on.
Dr Mohamed Khereba (Montreal, Quebec, Canada). You
compared your QOLwith hypertension and patients with renal dis-
ease. What kind of renal disease exactly? Is it terminal renal dis-
ease or just a patient with a different creatinine? What kind of
liver disease? A patient with severely debilitating liver disease
or not? If we are comparing pneumonectomy with a patient with
just working hypertension who has better control with 1 or 2 med-
ications, it’s not a disease as we would call it.
Dr Bryant. That’s an excellent question and a comment. I think
that’s one of the limitations of our study. The definitions of those
diseases were not clear. The reason that we used these data to
show as comparison data is that it’s really actually one of the
few data points that we found that is comparable, and it’s also re-
leased by the same company that makes the SF-12. So we felt that
it was comparable, but perhaps not the ideal.
Dr Khereba. I would suggest maybe you can compare them
with terminal renal disease, with very severe chronic obstructive
pulmonary disease, with patients after pneumonectomy with
some debilitating disease with a patient who has a very morbid
procedure like pneumonectomy.
Dr Joseph B. Shrager (Stanford, Calif). In most studies that
have looked at this, the control group is lobectomy patients. I
don’t know if you have the data, but you probably really want to
compare pneumonectomy patients with lobectomy patients.diovascular Surgery c Volume 144, Number 5 1145
